Diabetes & Endocrinology
Lonapegsomatropin Once-Weekly Therapy Shows Comparable Efficacy to Daily Somatropin in Turner Syndrome: 52-Week Outcomes from the New InsiGHTS Trial
This phase 2 trial demonstrates that once-weekly lonapegsomatropin matches daily somatropin in improving height velocity and safety in children with Turner syndrome over 52 weeks, offering a promising alternative to daily injections.
